Legato Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-101,842
| Closed | -$501K | – | 631 |
|
|
2024
Q1 | $501K | Buy |
101,842
+44,190
| +77% | +$217K | 0.06% | 439 |
|
|
2023
Q4 | $507K | Buy |
57,652
+18,903
| +49% | +$166K | 0.07% | 414 |
|
|
2023
Q3 | $444K | Sell |
38,749
-1,017
| -3% | -$11.7K | 0.06% | 424 |
|
|
2023
Q2 | $1.01M | Buy |
39,766
+6,324
| +19% | +$160K | 0.14% | 258 |
|
|
2023
Q1 | $1.08M | Hold |
33,442
| – | – | 0.2% | 175 |
|
|
2022
Q4 | $617K | Buy |
+33,442
| New | +$617K | 0.12% | 285 |
|